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Overall, this study seems to be well thought-through, based on relevant theory and previous literature, and sufficient attention has been paid to possible bottlenecks of RCT's. The protocol is written with attention to privacy issues, and seems feasible. Since recruitment has most likely already started, my suggestions focus on clarification for the rationale and details of the method.
Abstract: -Why do the authors focus specifically on the associated mental symptoms related to somatic symptoms? As it is becoming clearer that students experience more and more mental health issues, I would think that it would also be relevant to focus directly on mental health issues, as the authors propose to examine the efficacy of a psychological intervention. The authors also mention this themselves on page 5, lines 53-57. I understand that the authors wish to study this relatively unstudied area (page 5, line 46), but more information on why this is a major issue in the specific population of university students would be helpful.
-Why have the authors chosen for only a short term follow-up (i.e. immediately after completion of the intervention)? A long-term follow-up (e.g. 6 months) could be helpful to also investigate the sustained beneficial effects of the intervention, especially since the last module focuses on relapse prevention.
Strengths and limitations: -The strengths and limitations (in which only strengths are mentioned) state that this study is the first study in Germany, and that a nationwide sample of students will be recruited. However, in the methods it says that students in three countries (Germany, Switzerland, and Austria) will be recruited.
Introduction: -I would suggest to reorder the paragraphs so that the second paragraph does not begin with referring to the previous one, which is usually avoided in English writing. -Page 2, lines 3-6: Could stigma and time students need to spend on finding and adhering to psychosocial care also be a challenge in providing adequate care to this sample? -Page 5: In lines 22-24 it is stated that IMI's in depression and anxiety are efficient (with medium and high effect sizes), while in line 43-44 the authors write that reviews indicate suboptimal efficacy of IMI's for distress or psychological outcomes. How should the reader interpret this evidence? -Page 6, line 14: Where does iSOMA stand for? Where does this name come from?
Methods: -Page 6, line 55: How will the eligibility criteria be assessed? -Page 7, line 7: How will informed consent be provided? Will everything be done online or will the authors use paper and pencil? And if online informed consent is provided, what are the ethical implications? -Page 7, line 16: Can an estimation be given as to when recruitment will be finished? What is the expected inclusion rate per month and how will recruitment continue over time (i.e. will all recruitment actions be repeated throughout)? -Will all students start soon after inclusion, consecutively? Or do they have to wait until the whole group is recruited? And related, when will the WLCG start? -Page 8, line 43: What is meant by 'voluntary' text messages? Is this service optional? -Page 8, line 55: Why will the WLCG receive the unguided version? Is this ethical since the authors screen on the presence of somatic symptom disorder? Additionally, if the waitlist control group receives the unguided version of the intervention, how will the post-intervention scores of both arms be compared? And if this will not be done, for what purpose will the post-WLCG (T2) scores be used? -Page 10, line 58: The authors say that with will examine adverse events with the INEP. However, the answer options also indicate a possibility of positive side effects ("worse/better relationship with family). Will this also be assessed? -Page 11, line 7: Why is no clinical change assessed as a possible negative effect of the intervention? -Page 11, line 26: How will the WAI be adapted? Is this suitable in the case of i-coaches? -Page 11, line 34: Is this a 5 or 4-point scale (1 to 4)? Sample size estimation: -How is drop-out taken into account? Both drop-out from the intervention as from completing the questionnaires.
-What is the prevalence rate of somatoform disorder in German university students? How may students are addressed and what is the expected response rate and level of eligibility? Can an estimation be provided?
Ethical issues: -Great care is taken by the authors to ensure appropriate care in case of students with suicidal ideation. However, I wonder whether these students should be eligible at all. These vulnerable group of students should be given immediate psycho-social care and may not be up for participation in a study, especially one with a WLCG and only online support. How will this be addressed?
Discussion: -The discussion will address several expected challenges in conducting this trial. However, the first and final points do, in my opinion, not really address expected challenges in conducting the trial, but focus largely on relevance. -Page 13, line 40: What is meant by "a phenomenon of great transdiagnostic relevance"? -Page 14, line 37: "…if reasons for dropping out include…" How will the reasons for drop-out be assessed? This could be quite a challenge if students do not respond anymore.
-Page 14, line 12: What could be the influence of this decision of the results of the RCT and how findings could possibly be transferred to other populations? -Page 14, lines 15-27: How do these two points relate to the issue of recruitment and dropout? -Page 14, line 48: I would suggest to address the strengths of the study in a separate paragraph. Table 2 : -The list of questionnaires is extensive and many concepts are included. How much time will it approximately take to fill out all questionnaires? Additionally, the length of the questionnaires might influence the response rate as students usually are not very compliant in undertaking activities that do not have a direct benefit for them. Are there strategies in place to overcome such issues? 
GENERAL COMMENTS
The article entitled "Efficacy of a guided internet-based intervention (iSOMA) for somatic symptom distress in university students: study protocol of a randomized controlled trial" describes a RCT investigating the efficacy and feasibility of a guided internet-based intervention for college student experiencing somatic symptoms. Introducing internet-based treatments for this population is an excellent idea due to the acceptance of computer and internet-based technologies for this population, as well as potentially reducing the influence of stigma associated with mental health treatment (as discussed by the authors). It is also an excellent idea to incorporate the assessment of psychological features of somatic symptoms (i.e., DSM-5 Criteria B for Somatic Symptom Disorder) as they reference on page 9, lines 41-49. Furthermore, the secondary outcomes they measure are both appropriate, relevant, and will most likely be of interested to researchers and clinicians. Although this study holds much promise, I have some concerns regarding the proposed protocol. My concerns are as follows: 1. In the abstract, the authors state the study is for "students with moderate to severe somatic symptom burden" (Page 3, line 20); however, in the eligibility criteria, the authors state that participants need to score ≥4 on the Patient Health Questionaire-15 item version (PHQ-15) to be included in this study (page 7, line 3). As indicated by Kroenke and colleagues (2010), a score of 5-9 would be consistent with mild somatic symptom burden. This point should be clarified to help the reader better understand the severity of the symptoms treated. 2. The authors state that wait list control group will receive an unguided version of the internet-based intervention 8-weeks after randomization (page 8, line 55). Conversely, the intervention group will receive guidance throughout the intervention phase including semi-standardized feedback from trained psychologists (i-coach) and reminders to complete modules (Page 8, . If this guidance influences completion rates and improvements, it may be unethical to provide an inferior treatment to the wait list group (e.g., without guidance). Given that the waitlist control group does not control for attention (i.e., guidance and support) provided by the i-coach, the authors are unable to parse apart the influence of the stand-alone internet-based program versus the guidance and support from the i-coach. Furthermore, the authors have stated a belief that the guidance will "reinforce self-efficacy and adherence" (page 8, line 33), providing further confusion as to their choice not to provide guidance to the wait-list control group. Therefore, it is unclear if the treatment offered to those participants randomized to the wait-list control group will be equal to the treatment offered to the intervention group. 3. The authors use the abbreviations T0, T1, and T2 on Table 2 to indicate their assessment time-points (Table 2, Page 18, line 19 ), yet use the abbreviations T1, T2, and T3 in the text (Page 9, line 9-10). This discrepancies creates confusion when reading Table 2 . The authors should adjust the abbreviations to be consistent throughout the report. Likewise, the authors do not indicate the meaning to T0, T1, and T2 in Note for Table 2 , which requires the reader to refer back in the text to determine the meaning of these time points. To make interpretation easier and to allow the table to be self-explanatory, the authors should detail the meaning of these abbreviations in the table note. 4. It is a wonderful idea to assess the influence of therapeutic alliance on the treatment outcomes (as indicated on page 11, line 15-27). However, the authors reported choice of time (at baseline, which I believe is the meaning of T0, see #3 above) to assess the therapeutic alliance is confusing ( (Nezlek, 2012) , and provide analyses more robust against missing data (Howell, 2008) . They could also examine potential mediating and moderating variables within the model without having to conduct additional regression analyses as indicated on Page 13, lines 21-24. Furthermore, given the nested nature of the data (e.g., assessment point within participant within i-couch within university within country), it would allow the authors to examine and control for nesting in the influence of nesting and cross level interactions (e.g., the intervention being more efficacious on a given person in a certain university). The authors are encouraged to look into using MLM for analyses. 8. On page 9, lines 32-38, the authors discuss the PHQ-15. They mention the items encompass symptoms commonly found in primary care; however, it is unclear if these are also symptoms commonly found on college campuses. It is unclear if similar symptoms can be found in college students or if the authors may encounter a floor effect many students reporting lower levels of symptoms whom may also be experiencing symptoms not measured by the PHQ 15. Similarly, if the measure is unable to adequately identify somatic symptoms in college students, it is unclear if the measure will be able to detect change in symptoms in this population. To allow the reader to determine the appropriateness of this measure, the authors should stipulate their reasoning for using this measure on college campuses, as other somatic symptom measures have been used on college campuses. 9. In the introduction (Pages 4 and 5), the author switches between the use of somatic symptom distress, chronic somatic symptoms, chronic somatic conditions, polysymptomatic somatoform syndromes, somatoform disorder, and somatic symptom disorder which is confusing. The authors should reword the introduction to ensure consistency in the wording in order to reduce confusion (e.g., only using somatic symptom distress and somatic symptom disorder). 10. Similarly, the author references study 40 (page 5, lines 44-49) regarding a study examining the efficacy of an internet-based study for health anxiety in individuals with somatic symptoms disorder and health anxiety. Although these disorders tend to cooccur, current literature conceptualized health anxiety as different from somatic symptom distress (see APA, 2013 12. On Page 7, line 50, the authors stated that "Within the course of the study, neither participants or study team can be blinded to allocation due to the nature of the intervention." Is this regarding the therapeutic intervention or the assessments? While this is true for the participants, it seems possible that the study team can be blinded for the assessments. This can be accomplished by dedicating specific persons to conduct assessments only for which randomization information is withheld (i.e., they are not sure what condition the participant is enrolled). Different individuals can then be dedicated as i-coach and to work with the intervention. Thus, some element of blinding can be attained for the study team.
VERSION 1 -AUTHOR RESPONSE
***General comments*** Overall, this study seems to be well thought-through, based on relevant theory and previous literature, and sufficient attention has been paid to possible bottlenecks of RCT's. The protocol is written with attention to privacy issues, and seems feasible. Since recruitment has most likely already started, my suggestions focus on clarification for the rationale and details of the method.
***Abstract*** (1) Why do the authors focus specifically on the associated mental symptoms related to somatic symptoms? As it is becoming clearer that students experience more and more mental health issues, I would think that it would also be relevant to focus directly on mental health issues, as the authors propose to examine the efficacy of a psychological intervention. The authors also mention this themselves on page 5, lines 53-57. I understand that the authors wish to study this relatively unstudied area (page 5, line 46), but more information on why this is a major issue in the specific population of university students would be helpful. Answer: Thank you for this considerate remark. To account for the interplay of somatic and mental processes in somatic symptoms, we clarified the study's objective so that it combines both aspects.
For that reason, we adapted the title:
"Efficacy of a guided Internet-based intervention (iSOMA) for somatic symptoms and related distress in university students: study protocol of a randomized controlled trial" Also, we added the term "and related distress" in the objectives section (p. 5).
Furthermore, as stated in the manuscript, not only is somatization common in (German) university students (9.1%, Bailer et al., 2008) but also are clinically relevant somatoform disorders (6.6%, Grobe & Steinmann, 2015) . However, despite the availability of effective treatment, only 1 in 5 students with mental health issues actually receives minimally adequate treatment (Auerbach et al., 2016) . We believe, the prevalence and undertreatment of university students with somatic symptoms and associated distress demonstrate the need for low-threshold interventions such as iSOMA.
Since chronic somatic symptoms and related distress can effectively be reduced with psychotherapy, we are confident, that an established psychological intervention can be applied to the selected target group. Above that, previous studies have documented the acceptance of IMIs in this population, which we reference in the discussion (p. 13). Also, the feasibility and effectiveness of IMIs in this target group (Davies, Morriss, & Glazebrook, 2014) corroborates this assumption.
To emphasize the evidence in the academic context according to your comment, we restructured the introduction, so that academic health and SSDs in university students represent a rather consistent section at the end of the introduction. To underline the need for IMIs in this specific population, we added prevalence rates for SSDs and emphasized the reduced uptake of medical services in students:
p. 5 "University students, in particular, show a higher risk of developing mental disorders than nonstudents, with increasing rates of severe mental health issues [17, 44] and reduced uptake of medical services [45] . A survey by Bailer and colleagues [46] found that 9.1% of university students of a major German university fulfilled the criteria for a subclinical somatoform syndrome. Also, SSDs represent the second most prevalent mental disorders (6.6%) in German university students according to an insurance report [47] ."
(2) Why have the authors chosen for only a short term follow-up (i.e. immediately after completion of the intervention)? A long-term follow-up (e.g. 6 months) could be helpful to also investigate the sustained beneficial effects of the intervention, especially since the last module focuses on relapse prevention. Answer: Thank you for this remark. We agree with you, that the inclusion of a long-term follow-up measurement would allow for a more comprehensive evaluation of the intervention. However, the partial cross-over research design (WLCK receives intervention after waiting time of 8 weeks) would not allow for a between-group comparison. In this regard, it would seem unethical to extend waiting time to a follow-up period (eg, 6 months). Furthermore, since the intervention is the first of its kind, the focus of the present research lies in the immediate efficacy. We thus believe that the current assessment is meaningful in judging the intervention's efficacy.
***Strengths and limitations*** (3) The strengths and limitations (in which only strengths are mentioned) state that this study is the first study in Germany, and that a nationwide sample of students will be recruited. However, in the methods it says that students in three countries (Germany, Switzerland, and Austria) will be recruited.
Answer: We apologize for the confusion regarding recruitment area and replaced the term "nationwide" by "international" and added "German-speaking", "young adults" for clarification in the "Strengths and limitations" section as well as in the abstract (p. 2). Also, we added challenges to the current study:
p. 2 "Challenges of this trial include the diverse target group and somatic conditions." ***Introduction*** (4) I would suggest to reorder the paragraphs so that the second paragraph does not begin with referring to the previous one, which is usually avoided in English writing. Answer: We merged the two paragraphs (p. 3) accordingly, thank you for pointing this out.
(5) Page 2, lines 3-6: Could stigma and time students need to spend on finding and adhering to psychosocial care also be a challenge in providing adequate care to this sample? Answer: We agree with you that these represent important barriers to uptake of psychosocial care. Accordingly, we included further information in the manuscript: p. 4 "In chronic physical conditions, reviews indicate a lower efficacy of IMIs for distress or psychological outcomes than for somatic symptoms [33, 34] ."
(7) Page 6, line 14: Where does iSOMA stand for? Where does this name come from? Answer: We added an explanation of this abbreviation to the main manuscript (p. 5) as well as in the list of abbreviations: iSOMA = Internet-based training for somatic symptoms ***Methods*** (8) Page 6, line 55: How will the eligibility criteria be assessed? Answer: Eligibility criteria will be assessed through online self-report. Subsequent information was added to the manuscript: p.8 "Eligibility criteria, outcomes, potential effect-modifying variables, and demographics will be assessed via self-report with validated questionnaires (approximately 20-30 minutes per questionnaire)."
(9) Page 7, line 7: How will informed consent be provided? Will everything be done online or will the authors use paper and pencil? And if online informed consent is provided, what are the ethical implications? Answer: Participants receive the informed consent as an appendix to an e-mail and can return a printed out signed copy of the form either by e-mail or postal. The information in the manuscript was clarified accordingly:
p.6 "Furthermore, (f) participants will need to provide a signed copy of the informed consent form via email or postal."
(10) Page 7, line 16: Can an estimation be given as to when recruitment will be finished? What is the expected inclusion rate per month and how will recruitment continue over time (i.e. will all recruitment actions be repeated throughout)? Answer: Thank you for your comment. Due to the pilot character of the present study regarding the target symptoms and population, reliable values for the recruitment period and the inclusion rate per months can hardly be estimated. Furthermore, these parameters vary substantially in RCTs by further research groups within the studicare-framework. Recruiting measures will be applied adaptively depending on the inclusion rate. Additionally, the universities associated with the studicare-framework inform students about various health care offers (including the interventions hosted on studicare) regularly throughout study terms. We added this information to the manuscript:
p. 6 "Recruiting measures will be applied adaptively depending on the inclusion rate."
(11) Will all students start soon after inclusion, consecutively? Or do they have to wait until the whole group is recruited? And related, when will the WLCG start? Answer: Intervention or waiting time starts directly and participants will be recruited consecutively. This information was added to the manuscript accordingly.
p.6 "Participants from Germany, Swiss or Austrian universities are recruited consecutively through online resources (eg, studicare platform, study web portal, social networks), newspapers or university press reports and academic institutions for student health (eg, student counseling, occupational health management, college sport etc.).
Furthermore, the section "Control condition" states, that the WLCG starts the intervention after a waiting period of 8 weeks.
p. 8 "Eight weeks post-randomization, the WLCG will receive iSOMA (…)"
(12) Page 8, line 43: What is meant by 'voluntary' text messages? Is this service optional? Answer: We replaced the word "voluntary" with "optional" as suggested by you (p. 7).
(13) Page 8, line 55: Why will the WLCG receive the unguided version? Is this ethical since the authors screen on the presence of somatic symptom disorder? Additionally, if the waitlist control group receives the unguided version of the intervention, how will the post-intervention scores of both arms be compared? And if this will not be done, for what purpose will the post-WLCG (T2) scores be used?
Answer: We thank you for this considerate remark. We agree, that providing the WLCG with an unguided version represents an ethical issue, in particular since unguided interventions are associated with lower adherence rates. Initially, this was implemented for economic reasons due to the workload associated with regular feedback from study participants. Based on research design of previous trials (Berger et al., 2011; Ebert et al., 2014; Rheker, Andersson, & Weise, 2015) , we decided to change this condition to contain guidance on demand. Participants of the former WLCG will be able to contact the e-Coach in the intervention platform and will receive an answer within two working days and reminders in case of inactivity as in the "regular feedback" condition. Also, we plan to investigate possible differences between the two intervention forms (regular feedback vs. feedback on demand) in explorative analyses. We added this information in the manuscript accordingly:
p.5 "Also, outcomes will be evaluated exploratively by comparing two levels of therapist guidance (regular feedback vs. feedback on demand) as applied in the two intervention arms (see figure 1 ) and the effect of optional short text messages."
p.8 "Participants in the WLCG have unrestricted access to usual treatment options. Eight weeks postrandomization, the WLCG will receive iSOMA with written e-coach contact on demand through the intervention platform, as proven to be effective in previous trials [61, 62] ." (14) Page 10, line 58: The authors say that with will examine adverse events with the INEP. However, the answer options also indicate a possibility of positive side effects ("worse/better relationship with family). Will this also be assessed? Answer: The item scores of the INEP can be subdivided into negative (-3 to -1), unchanged (0), and positive (1 to 3) (Ladwig, Rief, & Nestoriuc, 2014) . Based on previous trials (eg , Holsting, Pedersen, Rask, Frostholm, & Schröder, 2017) , for the present study, only the detection of negative events is of main interest, since clinical change or satisfaction is measured elsewhere.
(15) Page 11, line 7: Why is no clinical change assessed as a possible negative effect of the intervention? Answer: We crossed out the ambiguous term ("no clinical change").
(16) Page 11, line 26: How will the WAI be adapted? Is this suitable in the case of i-coaches? Answer: The WAI-SR has been adapted to evaluate therapeutic alliance in guided as well as unguided IMIs (Berger, 2017) . In the version for the participants in the regular feedback condition and the version for the e-Coaches, only minor changes were applied to the original version (patient -> participant; therapy -> online training; therapist -> e-Coach), which do not alter the meaning of the items. The version for the participants in the contact on demand condition was adapted from a previous study by Berger, Boettcher, and Caspar (2014) to measure alliance with the intervention rather than the therapist/e-Coach, e.g. "The goals of the online training are important goals for me to work on" or "Through the online training I have become clearer about the things I need to do to help improving my situation". Interestingly, previous research has demonstrated, that early alliance ratings in unguided interventions are positively related to the outcome (Meyer et al., 2015) . However, in the absence of a robust evidence base, we aim to explore the effect-modulating influence of alliance in a quasi-guided condition in this trial. Accordingly, we added relevant information to this section in the manuscript:
p. 10 "Thus, in the present study, the therapeutic alliance will be assessed in the early intervention phase (3 weeks after intervention start) from participants and the associated e-coach with an adapted version of the short form of the working alliance questionnaire (WAI-SR) [86] as used in previous trials [87] ."
"The version for the participants in the contact on demand condition will be adapted from a previous study [89] (2018) showed dropout rates ranging from 3.6% (CG) to 6.5% (IG). A review by Cuijpers, van Straten, and Andersson (2008) of 13 studies on various chronic somatic conditions yielded higher average dropout rates around 23%. Similarly, a review by Buhrman, Gordh, and Andersson (2016) on 22 IMIs for chronic pain average dropout rates were around 17%. Interestingly dropouts were lower than the average in unguided trials (7.1 -6.4%). Furthermore, trials investigating IMIs for various mental health issues in the relevant target group of university students yielded a wide range of dropout rates (Davies et al., 2014) . Taken together, a dropout rate of 20% is estimated for the current trial, considering the guidance and other adherence facilitating measures (e.g. reminders, SMScoach). We added the above-mentioned evidence on dropout rates, corrected estimated sample size in the manuscript and in figure 1. (Grobe & Steinmann, 2015) , as referenced in the manuscript (p. 5). Given the scalability of this trial to more than 150 universities and 300+ academic institutions (technical/art colleges) in three countries, of them 15 cooperating universities regularly informing students on the studicare health programs, we feel confident in reaching the estimated sample size. ***Ethical issues*** (20) Great care is taken by the authors to ensure appropriate care in case of students with suicidal ideation. However, I wonder whether these students should be eligible at all. These vulnerable group of students should be given immediate psycho-social care and may not be up for participation in a study, especially one with a WLCG and only online support. How will this be addressed? Answer: Research literature suggests that individuals with suicidal ideation should not be excluded from IMIs (Christensen et al., 2013; Watts, Newby, Mewton, & Andrews, 2012) for the following reasons: Individuals with suicidal ideation rarely seek professional help (Brook, Klap, Liao, & Wells, 2006) . In addition, a significant proportion of participants in trials with IMIs indicate that they do not otherwise use treatment and care services. Through the use of IMIs, these persons receive immediate, time-and location-independent additional care and can be referred to more intensive care mechanisms such as face-to-face psychotherapy. Recent studies have also shown that IMIs are also suitable for reducing suicidality (Madsen, van Spijker, Karstoft, Nordentoft, & Kerkhof, 2016; van Spijker, van Straten, & Kerkhof, 2014) . Also, because of the high comorbidity of somatoform disorders with depression (Brown, Golding, & Smith, 1990) , refusing to provide people with suicidal ideation with a potentially effective intervention would seem ethically problematic. Also, participants are informed beforehand that the Internet intervention does not replace medical and/or psychotherapeutic care and that they are free to use medical services while participating in the trial. Moreover, in case of substantial suicidality participants will even be urged to immediately contact appropriate at-site health care services which likely will increase the level of appropriate health care for participants with emerging suicidality. Through regular supervision, training of e-Coaches, application of evidencebased measures in suicide prevention, we thus believe, that the current trial is feasible for managing participants indicating suicidality.
***Discussion*** (21) The discussion will address several expected challenges in conducting this trial. However, the first and final points do, in my opinion, not really address expected challenges in conducting the trial, but focus largely on relevance. Answer: Thank you for this considerate remark. Consequently, we changed the order of the paragraphs to reflect relevance and challenges of the trial (p. 13-14).
(22) Page 13, line 40: What is meant by "a phenomenon of great transdiagnostic relevance"? Answer: We crossed out the term for clarification, accordingly.
(23) Page 14, line 37: "…if reasons for dropping out include…" How will the reasons for drop-out be assessed? This could be quite a challenge if students do not respond anymore. Answer: We agree with you, that assessing reasons for drop-out represents a (common) challenge in trials with remote interventions. These reasons will be assessed through e-mail contact with up to three reminders. We added subsequent information to the manuscript: p.10 "Reasons for attrition will be assessed via e-mail contact."
(24) Page 14, line 12: What could be the influence of this decision on the results of the RCT and how findings could possibly be transferred to other populations? Answer: Thank you for bringing up this issue. Consistent with the DSM 5 criteria of SSD, eligibility will not dependent on the non-explanation of somatic symptoms or diseases. We are aware that this would also include participants with diagnosed conditions in contrast to those with medically unexplained somatic symptoms (Petersen et al., 2018) . However, this allows for a low-threshold accessibility that may overcome existing barriers to psychosocial care in university students. Also, the diversity of somatic symptoms is welcome to test the generalizability of iSOMA as a transdiagnostic intervention. However, the heterogeneity will be addressed through subgroup analyses to investigate effect-modulating influences and characteristics of the target group. We added this information to the manuscript accordingly:
"Firstly, to allow for low-threshold access, inclusion criteria will comprise somatic symptoms irrespective of their primary cause (physical or psychological), following the DSM 5 classification of SSD. Although the expected clinical diversity is welcome to test the generalizability of iSOMA as a transdiagnostic intervention, heterogeneity needs to be considered in further analyses. Therefore, subgroup analyses will be performed to differentiate the sample characteristics and evaluate a potential effect-modulating influence of comorbid somatic disorders."
(25) Page 14, lines 15-27: How do these two points relate to the issue of recruitment and dropout? Answer: We agree, that the above-mentioned arguments did not fit in the described context. Accordingly, we decided to relocate and rephrase the text passage to clarify the beneficial effect of the CBT rationale against the background of a somatic-dominated health orientation.
p. 14 "Thirdly, individuals with chronic somatic symptoms tend to develop somatically dominated models for their symptoms and thus may hold negative attitudes towards mental health interventions [19, 21] , which could have implications for the accessibility of the intervention under study. Therefore, the intervention rationale [51] features a primarily somatic-oriented entrance and a gradual development of a multicausal psycho-biological explanatory model instead of an immediate introduction (see table  1 ). "
Furthermore, we rephrased the section on attrition and included strategies to facilitate adherence: [110] [111] [112] , which were addressed in the development of iSOMA and the research design such as a short intervention duration (8 weeks), availability of guidance (e-Coach, SMS-coach) [29, 113] , reminders in case of inactivity [114] and interactivity and variability of the intervention content (eg, multi-media based, responsive design) [115] . However, it needs to be considered, that a reduced treatment adherence is not necessarily an indicator of limited effectiveness, but can also express early recovery. Thus, we attempt to assess reasons for and timing of drop out in the present study."
(26) Page 14, line 48: I would suggest to address the strengths of the study in a separate paragraph. Answer: Thank you for this helpful comment, we changed the order of the paragraphs in the discussion, so that strengths are included in a separate, homogenous section at the end of the discussion (p. 14).
***Table 2*** (27) The list of questionnaires is extensive and many concepts are included. How much time will it approximately take to fill out all questionnaires? Additionally, the length of the questionnaires might influence the response rate as students usually are not very compliant in undertaking activities that do not have a direct benefit for them. Are there strategies in place to overcome such issues? Answer: According to your considerate remark, we added information on the time to fill out the assessments (20-30 minutes, see p. 8). We are aware of the demands on participants of completing questionnaires. For that reason, we included an intuitive, low-threshold online-questionnaire. Although participants are not reimbursed for the evaluation, they receive a "thank-you gift" in form of an individual summary-PDF of the intervention strategies after the post-treatment evaluation. Study participants are informed beforehand about the necessity of evaluation that however comes with a cost-free intervention. Answer: Thank you very much for making us aware of these typos and inaccurate punctuation, which we corrected thoroughly.
***General comments*** The article entitled "Efficacy of a guided internet-based intervention (iSOMA) for somatic symptom distress in university students: study protocol of a randomized controlled trial" describes a RCT investigating the efficacy and feasibility of a guided internet-based intervention for college student experiencing somatic symptoms. Introducing internet-based treatments for this population is an excellent idea due to the acceptance of computer and internet-based technologies for this population, as well as potentially reducing the influence of stigma associated with mental health treatment (as discussed by the authors). It is also an excellent idea to incorporate the assessment of psychological features of somatic symptoms (i.e., DSM-5 Criteria B for Somatic Symptom Disorder) as they reference on page 9, lines 41-49. Furthermore, the secondary outcomes they measure are both appropriate, relevant, and will most likely be of interested to researchers and clinicians. Although this study holds much promise, I have some concerns regarding the proposed protocol. My concerns are as follows:
(1) In the abstract, the authors state the study is for "students with moderate to severe somatic symptom burden" (Page 3, line 20); however, in the eligibility criteria, the authors state that participants need to score ≥4 on the Patient Health Questionaire-15 item version (PHQ-15) to be included in this study (page 7, line 3). As indicated by Kroenke and colleagues (2010), a score of 5-9 would be consistent with mild somatic symptom burden. This point should be clarified to help the reader better understand the severity of the symptoms treated. Answer: Thank you for your considerate remark on the classification of the PHQ-15 cut-off. The present cut-off was chosen based on findings from a recent, representative study in the German population (Laferton et al., 2017) . Here, a PHQ-value ≥ 4 proved to be the optimal sensitivity-focused criterion and was associated with a chance of a DSM 5 diagnosis of a Somatic Symptom Disorder (SSD) of .87, along with other advantageous parameter values (e.g. Diagnostic Likelihood Ratio (DLR) = 1.86, Negative Predictive Value (PPV) = .11). However, we agree, that that the information in the abstract is ambiguous and clarified the sentence as follows:
"As part of the "Studicare" project, the present study aims to recruit N = 154 university students indicating somatic symptom burden at baseline in German-speaking universities."
(2) The authors state that wait list control group will receive an unguided version of the internet-based intervention 8-weeks after randomization (page 8, line 55). Conversely, the intervention group will receive guidance throughout the intervention phase including semi-standardized feedback from trained psychologists (i-coach) and reminders to complete modules (Page 8, . If this guidance influences completion rates and improvements, it may be unethical to provide an inferior treatment to the wait list group (e.g., without guidance). Given that the wait-list control group does not control for attention (i.e., guidance and support) provided by the i-coach, the authors are unable to parse apart the influence of the stand-alone internet-based program versus the guidance and support from the i-coach. Furthermore, the authors have stated a belief that the guidance will "reinforce selfefficacy and adherence" (page 8, line 33), providing further confusion as to their choice not to provide guidance to the wait-list control group. Therefore, it is unclear if the treatment offered to those participants randomized to the wait-list control group will be equal to the treatment offered to the intervention group. Answer: We thank you for this considerate remark. We agree, that providing the WLCG with an unguided version represents an ethical issue, in particular since unguided interventions are associated with lower adherence rates. Initially, this was implemented for economic reasons due to the workload associated with regular feedback from study participants. Based on the research design of previous trials (Berger et al., 2011; Ebert et al., 2014; Rheker et al., 2015) , we decided to change this condition to contain guidance on demand. Participants of the former WLCG will be able to contact the e-Coach in the intervention platform and will receive an answer within two working days and reminders in case of inactivity as in the "regular feedback" condition. Also, we plan to investigate possible differences between the two intervention forms (regular feedback vs. feedback on demand) in explorative analyses. We added this information in the manuscript accordingly:
p.5 "Also, outcomes will be evaluated exploratively by comparing two levels of therapist guidance (regular feedback vs. feedback on demand) as applied in the two intervention arms (see figure 1 ) and the effect of optional short text messages." p.8 "Participants in the WLCG have unrestricted access to usual treatment options. Eight weeks postrandomization, the WLCG will receive iSOMA with written e-coach contact on demand through the intervention platform, as proven to be effective in previous trials [61, 62] ."
(3) The authors use the abbreviations T0, T1, and T2 on Table 2 to indicate their assessment timepoints (Table 2 , Page 18, line 19), yet use the abbreviations T1, T2, and T3 in the text (Page 9, line 9-10). This discrepancies creates confusion when reading Table 2 . The authors should adjust the abbreviations to be consistent throughout the report. Likewise, the authors do not indicate the meaning to T0, T1, and T2 in Note for Table 2 , which requires the reader to refer back in the text to determine the meaning of these time points. To make interpretation easier and to allow the table to be self-explanatory, the authors should detail the meaning of these abbreviations in the table note. Answer: Thank you very much, for pointing out this inconsistency. We adjusted the abbreviations and annotations in table 2 accordingly (see p. 17).
(4) It is a wonderful idea to assess the influence of therapeutic alliance on the treatment outcomes (as indicated on page 11, line 15-27). However, the authors reported choice of time (at baseline, which I believe is the meaning of T0, see #3 above) to assess the therapeutic alliance is confusing (Table 2 , page 18, line 46). It is not entirely clear the level of therapeutic alliance which will be generated prior to the start of the intervention. This variable may be best assessed post-intervention. Answer: Alliance ratings will be assessed at three weeks after intervention start, as indicated by annotation (c) in table 2. To avoid confusion with the baseline measurement (t1), we put the measurement point in brackets. Accordingly, we added the following information to the manuscript:
p.10 "Thus, in the present study, the therapeutic alliance will be assessed in the early intervention phase (3 weeks after intervention start) from participants and the associated e-coach with an adapted version of the short form of the working alliance questionnaire (WAI-SR) [86] as used in previous trials [87] ."
The timing of the alliance measurement is based on practice in previous trials that used early alliance ratings (within the first third of the intervention course) and proved its effect-modulating influence (Andersson et al., 2012; Berger et al., 2014; Meyer et al., 2015; Nordgren, Carlbring, Linna, & Andersson, 2013) . Furthermore, an early alliance rating has the advantage of not being confounded with intervention satisfaction or effectiveness and in comparison to a post-intervention rating that would also have a higher risk for attrition rates limiting the statistical power.
(5) The authors report that participants will have the option to voluntarily sign up for regularly sent text messages that are meant to motivate participant completion (SMS; page 8, lines 41-49). They also report on evidence suggesting such messages can increase efficacy and adherence (Page 8, line 46). Will this option be tracked and the influence of the text messages be examined? Given that the authors indicate the SMS messages are meant to motivate completion, it may also influence any therapeutic change over the course of the treatment. I think this information would be of interest to any researchers or clinicians that are considering incorporating motivational SMS messages into their treatment of somatic distress and internet-based treatments. It is unclear if this feature will be tracked and analyses conducted to determine its influence. Answer: We agree with you, that effect-or adherence modulating intervention elements such as the "SMS-coach" represent an interesting area of study and for clinical application. However, the current trial is not designed nor powered to test the influence of SMS messages rigorously, such as in a dismantling study. Yet, following your suggestion, we added information on the explorative analyses of the optional SMS.
(6) Although the authors do a good job explaining their assessment procedures in the text (Page 9, lines 8), they do not describe the procedure that will be used when they are unable to contact a participant for a follow-up assessment (at 8-and 16-weeks). Will a single attempt or multiple attempts be made? Is there a time-limit upon which the participants will be deemed to have missed the assessment or be categorized as a non-completer? If multiple attempts will be made without a timelimit, this could mean that participants are reporting well over the 16-week limit indicated in the article and would have implications on the findings. Answer: Thank you for this considerate remark on reminders. We added the following information to the manuscript accordingly:
p.8 "In case of non-compliance, up to three reminders will be sent via E-Mail within the week after invitation for the assessment, followed by contact via phone, after which participants will be characterized as non-completers."
(7) Although analyses of covariance (ANCOVA) is a reasonable method to analyze the proposed data, multilevel modelling (MLM) would most likely be a superior data analyses method and the authors should consider MLM for several reasons. First, it would increase the power of their analyses (Nezlek, 2008) , improve their parameter estimates (Nezlek, 2012) , and provide analyses more robust against missing data (Howell, 2008) . They could also examine potential mediating and moderating variables within the model without having to conduct additional regression analyses as indicated on Page 13, lines 21-24. Furthermore, given the nested nature of the data (e.g., assessment point within participant within i-couch within university within country), it would allow the authors to examine and control for nesting in the influence of nesting and cross level interactions (e.g., the intervention being more efficacious on a given person in a certain university). The authors are encouraged to look into using MLM for analyses. Answer: Thank you for pointing out an alternative analysis strategy. We agree with the abovementioned advantages of MLM. Although our study design includes various recruitment strategies and among these, recruitment at universities associated with Studicare, these are not considered study centers in the classical (i.e. multicentric) sense. As such, they are not suitable as context units per se. We crossed out the information on stratification (p. 6) accordingly. Above that, we are not planning to investigate country or therapist specific effects, for this is the first of its kind trial and also, e-coaches are only located in the study center at Mainz University. Furthermore, cross-level interactions would not be backed up by an adequate theoretical framework. The current research strategy allows for specific and efficient analyses for the relevant pre-post comparison, whereas MLM would be suited for longitudinal or multi-level research questions. In summary, nesting and cross-level interactions are not planned to be evaluated in the pilot study at hand. Furthermore, moderator/mediator analyses are performed exploratively and thus more liberate regarding statistical power. Above that, following a critical remark of reviewer 1, we increased the sample size to N = 154, which may have a beneficial effect on statistical power.
(8) On page 9, lines 32-38, the authors discuss the PHQ-15. They mention the items encompass symptoms commonly found in primary care; however, it is unclear if these are also symptoms commonly found on college campuses. It is unclear if similar symptoms can be found in college students or if the authors may encounter a floor effect many students reporting lower levels of symptoms whom may also be experiencing symptoms not measured by the PHQ 15. Similarly, if the measure is unable to adequately identify somatic symptoms in college students, it is unclear if the measure will be able to detect change in symptoms in this population. To allow the reader to determine the appropriateness of this measure, the authors should stipulate their reasoning for using this measure on college campuses, as other somatic symptom measures have been used on college campuses. Answer: In the study by Bailer et al. (2008) 9.1% of N = 1130 university students fulfilled the criteria for a somatoform syndrome as determined with the PHQ-15 (see p. 5). Also, Jasper, Hiller, Rist, Bailer, and Witthöft (2012) report findings from two large German student samples with average PHQ scores between 7.1 (N = 2708) and 7.3 (N = 782) with 11% -12% of the respondents fulfilling criteria for the somatoform syndrome. These studies demonstrate that somatization is common in university students. Additionally, the study by Jasper et al. (2012) proved the factorial structure and reliability in the academic context. In a systematic review on various instruments for somatic symptoms (e.g. PHQ-15, SCL-90, SOMS), Zijlema et al. (2013) concluded that in comparison, the PHQ-15 possesses optimal psychometric properties, contains relevant symptoms, is short and thus can be administered easily, which makes this instrument suitable in the present research context.
(9) In the introduction (Pages 4 and 5), the author switches between the use of somatic symptom distress, chronic somatic symptoms, chronic somatic conditions, polysymptomatic somatoform syndromes, somatoform disorder, and somatic symptom disorder which is confusing. The authors should reword the introduction to ensure consistency in the wording in order to reduce confusion (e.g., only using somatic symptom distress and somatic symptom disorder). Answer: We agree with you, that the introduction contains a variety of terms for the research phenomenon. This variety is partly attributable to various levels of description (symptom -syndrome -disorder), qualities (somatic, mental, mono-(functional)/polysymptomatic) and in particular diagnoses (somatoform disorder, somatic symptom disorder), that are specific to the reported prevalence rates. However, we carefully checked for consistency and addressed your issue with standardizing some terms and preferably use "somatic symptom disorder" or "SSD" throughout the introduction (p. 3, 4).
(10) Similarly, the author references study 40 (page 5, lines 44-49) regarding a study examining the efficacy of an internet-based study for health anxiety in individuals with somatic symptoms disorder and health anxiety. Although these disorders tend to co-occur, current literature conceptualized health anxiety as different from somatic symptom distress (see APA, 2013) . That is, one can experience somatic symptoms without associated health anxiety and vice versa. Somatic symptoms were not assessed in the previous study they discuss. If the authors are going to discuss this study, they should reference how somatic symptoms were not assessed, which would bolster their argument for conducting their study. Answer: Thank you for pointing this out. In fact, the study by Hedman, Axelsson, Andersson, Lekander, and Ljótsson (2016) did not dimensionally assess the level of somatization or somatic symptoms but performed a clinical diagnostic with validated instruments, including the assessment of somatic disorders and the DSM 5 criteria for SSD (see p. 2). We agree with you, that including SSD but not assessing somatization represents a limitation of the above-mentioned study. In reviewing the literature, we found a similar, recent study by Newby et al. (2018) , which we included in the manuscript along with a conclusion on limited generalizability:
p. 4 "Above that, studies investigating IMIs for SSD are scarce: Hedman and colleagues [40] investigated a guided Internet-based CBT (iCBT) in a mixed sample including participants with SSD (n = 114 / 86.4%) and yielded large effect on health anxiety (SMD = 1.27, 95% CI: 0.72-1.79) but not for depression in comparison to a wait-list control group. Similarly, an Australian study testing a guided iCBT against a psychoeducation control group found high effects for the reduction of health anxiety in a sample including participants with SSD. However, these studies focused on health anxiety and as such did not assess the level of somatization, limiting their generalizability to SSDs."
(11) On page 6, line 46, the authors state that both groups will have unrestricted access to treatment as usual. In addition, on Page 11, line 50, the authors use medical treatment as an example of medical covariate. Is mental health treatment being tracked and examine as a covariate and/or an outcome measure? This will be important as it is feasible that one group may have increased motivation to seek treatment as compared to the author, particularly because the intervention condition includes psychoeducation on stress reactions. If TAU is unequal between groups, this would influence conclusions. Similarly, it would be of interest to determine as a secondary outcome if the internet intervention influenced the likelihood to seek out treatment (both medical and mental health). If the iSOMA program reduces medical utilization, it would be more likely to be used by clinicians and university seeking to decrease such variables. The authors should further explicate their tracking of TAU and if/how the TAU variable(s) will be used in analyses (e.g., covariate, secondary outcome measure, etc.). Answer: Thank you for this considerate remark. As stated in the manuscript (p. 11, section "covariates"), parallel health care utilization (HCU) will be assessed. However, in our target group we expect the level of symptom severity and thus health care utilization (HCU) to be less pronounced than in clinical samples, based on previous findings (Weiss, Mewes, Rief, & Kleinstäuber, 2017) . Against this background, we believe that HCU has limited sensitivity to be included as an outcome in the current trial. Nevertheless, HCU will be assessed as a covariate at baseline and post-treatment, which we clarified in table 2 (p. 18). Also, we crossed out the following sentences in eligibility criteria to avoid redundancy to the section "covariates":
p.6 "In order to facilitate generalizability of study results, no further exclusion criteria are applied. However, medical diagnoses, any form of parallel (eg, medical, psychotherapeutic, pharmacological) treatment will be monitored and analyzed."
(12) On Page 7, line 50, the authors stated that "Within the course of the study, neither participants nor study team can be blinded to allocation due to the nature of the intervention." Is this regarding the therapeutic intervention or the assessments? While this is true for the participants, it seems possible that the study team can be blinded for the assessments. This can be accomplished by dedicating specific persons to conduct assessments only for which randomization information is withheld (i.e., they are not sure what condition the participant is enrolled). Different individuals can then be dedicated as i-coach and to work with the intervention. Thus, some element of blinding can be attained for the study team. Answer: We thank you for pointing this out. We see that blinding mechanisms have not been described correctly in the manuscript. We thus corrected the term "study team" into "e-coaches" (p. 7) to clarify the blinding of personnel. The subsequent sentence describes the blinding of outcome assessors:
"An employee outside the research team will feed data into the computer in separate datasheets so that the researchers can analyze data without having access to information about the allocation."
---------------------------Further changes ---------------------------
(A) The start of recruitment was adapted (p. 6 / section "Setting/Recruitment"). The study is now actively recruiting.
(B) To ensure balanced sample sizes in the two study arms, information on variable block sizes (2, 4, 6) was added.
(C) The term "i-Coach" was changed to "e-Coach".
(D) To strengthen the conciseness of the discussion and avoid redundancy, the following passage has been crossed out:
p. 13 "Academic mental health care has not been applied systematically yet. This is problematic regarding the early onset, high prevalence rates and associated stigma of mental disorders [20, 43, 106] , which is in contrast to the low uptake rates of professional healthcare instruments [17, 105] .
Also, the following passage was relocated to the end of the discussion section:
p. 15 "Thus, the study results will have extensive implications for researchers, health professionals and academic mental health care"
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